As the risks of allogeneic blood transfusion (ABT)–transmitted viruses were reduced to
exceedingly low levels in the US, transfusion-related acute lung injury (TRALI), hemolytic …

Genomics is affecting all areas of medicine. In transfusion medicine, DNA-based genotyping
is being used as an alternative to serological antibody-based methods to determine blood …

BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) is a severe disease,
resulting from maternal red cell (RBC) alloantibodies directed against fetal RBCs. The effect …

Es frecuente la presencia de pruebas de compatibilidad positivas en pacientes que
requieren soporte transfusional. Los pacientes con anemia hemolítica autoinmune …

Alloimmunization to red blood cell (RBC) antigens represents a challenge for physicians
caring for women of child bearing potential. Exposure to non-self RBC antigens may occur …

After reviewing the relative frequency of the causes of allogeneic blood transfusion-related
mortality in the United States today, we present 6 possible strategies for further reducing …

Red blood cell (RBC) transfusion is unique as a common large-scale intravenous
introduction of foreign tissue and provides a valuable opportunity to study human …

Background There are more than 300 known red blood cell (RBC) antigens and 33 platelet
antigens that differ between individuals. Sensitisation to antigens is a serious complication …

The β thalassemia syndromes constitute the most frequent inherited anemia managed with
chronic red cell transfusions around the world. 1, 2 The prevalence of thalassemia in the …

Context.—Serious noninfectious complications are far more likely to occur than viral disease
transmission from blood component transfusion. Objective.—To compile a comprehensive …